查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1433372

全球更年期市場 2023-2030

Global Menopause Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 240 Pages | 商品交期: 2-3個工作天內

價格

預計在預測期內（2023-2030），全球更年期市場將以 5.37%的CAGR成長。市場的成長歸因於醫療保健支出的增加。隨著人們對健康和福祉的日益關注，更年期管理和緩解產品及服務的支出也隨之增加。例如，2023年7月，Slimming Sprinkles推出了一個專為圍停經期、更年期或絕經後以及經歷重大荷爾蒙和生理變化的女性設計的綜合性新在線平台，為更年期女性提供準確且經過充分研究的資訊。

細分市場前景

全球更年期市場依組件、部署模式、組織規模和產業垂直細分。根據組件，市場分為解決方案和服務。根據部署模式，市場分為本地部署和雲端部署。根據組織規模，市場分為大型企業和中小企業。此外，根據垂直產業，市場細分為消費品和零售、製造、能源和公用事業、運輸和物流、航空航太和國防、IT和電信、醫療保健和生命科學等。 OTC 藥品子類別預計將佔據該產品領域的很大一部分市場佔有率。這可以歸因於製藥公司生產用於治療更年期症狀的非處方藥的潛力的轉變。

膳食補充劑細分市場預計將在全球更年期市場中佔據相當大的佔有率

在治療領域中，膳食補充劑細分市場預計將在全球更年期市場中佔據相當大的佔有率。細分市場的成長歸因於消費者的偏好。天然或植物療法越來越受歡迎，尤其是在更年期女性中。具有多系統優勢並由天然來源生產的補充劑經常受到這一人群的熱烈歡迎。例如，2022年 10月，PharmaLinea 推出了先進的「全身」更年期補充品。它不僅可以緩解疼痛，還有益於心臟代謝、大腦和骨骼健康。研究發現，與安慰劑相比，Meno Ease 可將疼痛強度降低 27%。這表明它是一種有效的更年期補充劑，對受雌激素水準降低影響的各個身體系統具有潛在的益處。

區域展望

全球更年期市場根據地理位置進一步細分，包括北美（美國和加拿大）、歐洲（英國、義大利、西班牙、德國、法國和歐洲其他地區）、亞太地區（印度、中國、日本、韓國、亞洲其他地區）以及世界其他地區（中東和非洲以及拉丁美洲）。其中，由於該類別同時包含發展中經濟體和已開發經濟體，預計亞太地區將在全球市場中佔據顯著佔有率。醫療保健成本的上升預計將推動該行業的發展。日本等人口老化國家的發展預計將推動該地區的市場。

北美地區預計全球更年期市場複合CAGR顯著成長

在所有地區中，北美地區預計在預測期內將以相當大的CAGR成長。區域成長歸因於健康和保健意識。隨著人們健康意識的增強，並尋求隨著年齡的成長保持令人滿意的生活水準的策略，人們對更年期相關的健康產品和服務越來越感興趣。這一趨勢推動更年期市場向前發展。根據全球公共衛生，2020年11月，工業化國家的平均停經年齡為51歲，預期壽命為80.8歲。這意味著女性大約三分之一的壽命是在更年期後度過的。在美國，每天約有 6,000 名女性進入更年期，每年約有200 萬人進入更年期。

市場參與者展望

服務更年期市場的主要公司包括Bayer AG, Dr.Reddy's Laboratories Ltd, Merck & Co., Inc., Novo Nordisk A/S, Procter & Gambleand等。市場參與者透過各種策略（包括併購、夥伴關係、合作、融資和新產品發布），為市場成長做出了巨大貢獻，以保持市場競爭力。例如，2022年 11月，Northwell Holdings 與 Aegis Ventures 合作成立了 Upliv，這是一家女性虛擬護理新創公司，希望為臨床更年期支持設定標準。 Upliv 與公司合作，為患有圍停經期和更年期症狀的員工提供虛擬遠距醫療服務以及全人護理。

報告涵蓋：

  • 2022年市場價​​值資料分析及2030年預測。
  • 每個細分市場的年化市場收入（百萬美元）。
  • 主要地理區域的國家分析。
  • 在全球更年期市場中營運的主要公司。根據現有資料，報告中還提供了與新產品發布相關的資訊以及相關新聞。
  • 透過確定未來強勁成長的關鍵細分市場來分析業務策略。
  • 市場進入和市場擴張策略分析。透過識別市場中「誰的立場」來制定競爭策略。

目錄

第1章 報告摘要

  • 目前行業分析及成長潛力展望
  • 研究方法和工具
  • 市場區隔
    • 依細分
    • 依地區

第2章 市場概述與見解

  • 報告範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 建議
    • 結論

第3章 競爭格局

  • 主要公司分析
  • Abbott Healthcare Pvt.ltd.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • AbbVie
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • At F. Hoffmann-La Roche Ltd
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 關鍵策略分析

第2章 市場細分

  • 依治療分類的全球更年期市場
    • 膳食補充劑
    • 非處方藥產品
      • *荷爾蒙
      • *非荷爾蒙
  • 依給藥途徑分類的全球更年期市場
    • 專題
    • 注射
    • 口服
  • 依配銷通路分類的全球更年期市場
    • 機構銷售
    • 零售銷售
    • 網路銷售

第3章 區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第4章 公司簡介

  • Bayer AG
  • Bionova
  • Biosante
  • Church & Dwight Co., Inc.
  • Dr.Reddy's Laboratories Ltd.
  • Duchesnay
  • Eli Lilly and Company India Pvt. Ltd.
  • Merck & Co., Inc.
  • Novo Nordisk A/S
  • Padagis US LLC
  • Pfizer
  • Procter & Gamble
  • Pure Encapsulations
  • Teva Pharmaceutical Industries Ltd.
  • Theramex HQ UK Ltd.
Product Code: OMR2027953

Global Menopause Market Size, Share & Trends Analysis Report by Treatment (Dietary Supplements, OTC Pharma Products, Hormonal, and Non-hormonal), by Route of Administration (Topical, Injectable, and Oral), and by Distribution Channel (Institutional Sales, Retail Sales, and Online Sales), Forecast Period (2023-2030)

The global menopause market is anticipated to grow at a CAGR of 5.37 % during the forecast period (2023-2030). The market's growth is attributed to increasing healthcare expenditure. With an increasing focus on health and wellbeing, there is an increase in spending on menopausal management and relief products and services. For instance, in July 2023, Slimming Sprinkles launched a comprehensive new online platform designed exclusively for women who are perimenopausal, menopausal, or postmenopausal and experiencing major horm and physiological changes to provide accurate and well-researched information to menopausal women.

Segmental Outlook

The global menopause market is segmented on the component, deployment mode, organization size and industry vertical. Based on the component, the market is sub-segmented into solution, and services. Based on the deployment mode, the market is sub-segmented into on-premise, and cloud. Based on the organization size, the market is sub-segmented into large enterprises, and small & medium sized enterprises. Furthermore, on the basis of industry vertical, the market is sub-segmented into consumer goods and retail, manufacturing, energy and utilities, transport and logistics, aerospace and defense, it and telecom, healthcare and life sciences, and others. The OTC Pharma Products subcategory is expected to capture a significant portion of the market share within the product segment. This can be attributed to pharmaceutical companies' shifting potential of manufacturing OTC medications for the treatment of menopausal symptoms.

The Dietary Supplements Sub-Segment is Anticipated to Hold a Considerable Share of the global Menopause Market

Among the treatment, the dietary supplements sub-segment is expected to hold a considerable share of the global menopause market. The segmental growth is attributed to the consumer preferences. Natural or plant-based therapies have grown more popular, particularly among menopausal women. Supplements that provide multi-system advantages and are produced from natural sources are frequently warmly received by this demographic. For instance, in October 2022, PharmaLinea launched advanced 'whole body' menopause supplement. It offers pain relief in addition benefiting cardio-metabolic, brain, and bone health. Meno Ease' has been found to reduce pain intensity by 27% compared to a placebo. This indicates that it is an effective menopause supplement with potential benefits for various body systems affected by reduced oestrogen levels.

Regional Outlook

The global menopause market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to category contains both developing and developed economies. Rising healthcare costs are projected to fuel the industry. The development of countries with increasing aging populations, such as Japan, is expected to drive the market in the region.

The North America Region is Expected to Grow at a Significant CAGR in the global Menopause Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the health and wellness awareness. As individuals have grown health-conscious and seek strategies to preserve a satisfactory standard of life as they age, there is a growing interest in menopause-related health products and services. This trend is propelling the menopausal market forward. According to the Global Public Health, in November 2020, the average age of menopause in industrialized countries is 51 years, and life expectancy is 80.8 years. This means that women spend around one-third of their lifespan in postmenopause. In the US, around 6,000 women reach menopause daily, and approximately 2 million reach menopause every year.

Market Players Outlook

The major companies serving the menopause market includes Bayer AG, Dr.Reddy's Laboratories Ltd, Merck & Co., Inc., Novo Nordisk A/S, Procter & Gambleand others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in November 2022, Northwell Holdings partnered with Aegis Ventures the formation of Upliv, a women's virtual care start-up that desires to set the bar for clinical menopause support. Upliv collaborates with companies to provide virtual telemedicine services in addition to whole-person care to employees suffering from perimenopause and menopausal symptoms.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global menopause market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies. Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Abbott Healthcare Pvt.ltd.
    • 1.1.1. Overview
    • 1.1.2. Financial Analysis
    • 1.1.3. SWOT Analysis
    • 1.1.4. Recent Developments
  • 3.3. AbbVie
    • 1.1.5. Overview
    • 1.1.6. Financial Analysis
    • 1.1.7. SWOT Analysis
    • 1.1.8. Recent Developments
  • 3.4. At F. Hoffmann-La Roche Ltd
    • 1.1.9. Overview
    • 1.1.10. Financial Analysis
    • 1.1.11. SWOT Analysis
    • 1.1.12. Recent Developments
  • 1.2. Key Strategy Analysis

2. Market Segmentation

  • 2.1. Global Menopause Market by Treatment
    • 2.1.1. Dietary Supplements
    • 2.1.2. OTC Pharma Products
      • 2.1.2.1. *Hormonal
      • 2.1.2.2. *Non-hormonal
  • 2.2. Global Menopause Market by Route of Administration
    • 2.2.1. Topical
    • 2.2.2. Injectable
    • 2.2.3. Oral
  • 2.3. Global Menopause Market by Distribution Channel
    • 2.3.1. Institutional Sales
    • 2.3.2. Retail Sales
    • 2.3.3. Online Sales

3. Regional Analysis

  • 3.1. North America
    • 3.1.1. United States
    • 3.1.2. Canada
  • 3.2. Europe
    • 3.2.1. UK
    • 3.2.2. Germany
    • 3.2.3. Italy
    • 3.2.4. Spain
    • 3.2.5. France
    • 3.2.6. Rest of Europe
  • 3.3. Asia-Pacific
    • 3.3.1. China
    • 3.3.2. India
    • 3.3.3. Japan
    • 3.3.4. South Korea
    • 3.3.5. Rest of Asia-Pacific
  • 3.4. Rest of the World

4. Company Profiles

  • 4.1. Bayer AG
  • 4.2. Bionova
  • 4.3. Biosante
  • 4.4. Church & Dwight Co., Inc.
  • 4.5. Dr.Reddy's Laboratories Ltd.
  • 4.6. Duchesnay
  • 4.7. Eli Lilly and Company India Pvt. Ltd.
  • 4.8. Merck & Co., Inc.
  • 4.9. Novo Nordisk A/S
  • 4.10. Padagis US LLC
  • 4.11. Pfizer
  • 4.12. Procter & Gamble
  • 4.13. Pure Encapsulations
  • 4.14. Teva Pharmaceutical Industries Ltd.
  • 4.15. Theramex HQ UK Ltd.

LIST OF TABLES

  • 1. GLOBAL MENOPAUSE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 2. GLOBAL DIETARY SUPPLEMENTS MENOPAUSE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL OTC PHARMA PRODUCTS MENOPAUSE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL HORMONAL MENOPAUSE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL NON-HORMONAL MENOPAUSE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL MENOPAUSE MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION , 2022-2030 ($ MILLION)
  • 7. GLOBAL MENOPAUSE TOPICAL MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL MENOPAUSE INJECTABLE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL MENOPAUSE ORAL MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL MENOPAUSE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 11. GLOBAL MENOPAUSE FOR INSTITUTIONAL SALES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL MENOPAUSE FOR RETAIL SALES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL MENOPAUSE FOR ONLINE SALES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL MENOPAUSE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN MENOPAUSE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN MENOPAUSE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN MENOPAUSE MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION,2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN MENOPAUSE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 19. EUROPEAN MENOPAUSE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 20. EUROPEAN MENOPAUSE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 21. EUROPEAN MENOPAUSE MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2022-2030 ($ MILLION)
  • 22. EUROPEAN MENOPAUSE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 23. ASIA-PACIFIC MENOPAUSE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 24. ASIA-PACIFIC MENOPAUSE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 25. ASIA-PACIFIC MENOPAUSE MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2022-2030 ($ MILLION)
  • 26. ASIA-PACIFIC MENOPAUSE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD MENOPAUSE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD MENOPAUSE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD MENOPAUSE MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION,2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD MENOPAUSE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL MENOPAUSE MARKET SHARE BY TREATMENT, 2022 VS 2030 (%)
  • 2. GLOBAL DIETARY SUPPLEMENTS MENOPAUSE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL OTC PHARMA PRODUCTS MENOPAUSE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL HORMONAL MENOPAUSE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL NON-HORMONAL MENOPAUSE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL MENOPAUSE MARKET SHARE BY ROUTE OF ADMINISTRATION, 2022 VS 2030 (%)
  • 7. GLOBAL MENOPAUSE TOPICAL MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL MENOPAUSE INJECTABLE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL MENOPAUSE ORAL MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL MENOPAUSE MARKET SHARE BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
  • 11. GLOBAL MENOPAUSE FOR INSTITUTIONAL SALES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL MENOPAUSE FOR RETAIL SALES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL MENOPAUSE FOR ONLINE SALES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL MENOPAUSE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. US MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. CANADA MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. UK MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. FRANCE MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. GERMANY MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. ITALY MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. SPAIN MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF EUROPE MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. INDIA MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. CHINA MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. JAPAN MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. SOUTH KOREA MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. REST OF ASIA-PACIFIC MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)